Pharma Mar SA

(PHMMF)

By |

Profile

Pharma Mar SA develops and commercializes YONDELIS in Europe and has three clinical-stage programs under development, in addition to trabectedin, for several types of solid and hematological cancers, PM1183, plitidepsin, and PM60184.

Contact Information

Website: www.pharmamar.com
Email: info_ri@zeltia.com
Main Phone: +34 918466000
Address: Avda. De los Reyes, 1
Address 2: Pol. Ind. La Mina
City / Town: Madrid
Country: ESP
Postal Code: 28770

Issuer Information

Exchange: OTO
Employees: 700
$ 3.63 $ 0.14 (3.86%)
Last Price 3.63 Change $ 0.14 Change % 3.86 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 3.57 High 3.63 Low 3.57 Prev Close 3.50
Last Trade Volume 8,600 52 Wk Hi 3.78 52 Wk Low 2.13
Market Cap 802.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 220,994,806.00 EPS (TTM) -0.12 PE Ratio N/A Exchange OTCPK